Domestic pharmaceutical retail growth shows strong signs of demand-led expansion. Volume growth in June exceeded three percent, a significant positive shift. Industry growth outlook is now revised upwards to over eleven percent this year. Higher sales of lipid-lowering and cardiac therapies led the market’s recent surge. Chronic therapies continue to outpace the market, driven by lifestyle diseases.
